Madrigal Pharmaceuticals (MDGL) EBIT Margin (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported EBIT Margin of 12.98% for Q3 2026, up 52.66 percentage points from -39.68% a year earlier and up 28.44 percentage points from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBIT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Madrigal Pharmaceuticals' EBIT Margin came in at -10.69%, up 30.83 percentage points year-over-year; for FY2025, it was -31.31%, up 245.08 percentage points from FY2024.
- By year, EBIT Margin came in at -276.39% in FY2024.
- The Q3 2026 figure ranks as the highest quarterly EBIT Margin in data going back to Q2 2010.
- Year over year, EBIT Margin has now increased in each of the last six quarters, with an average year-over-year change of +228.21 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at -15.46% (Q2 2026), -29.78% (Q1 2026) and -18.56% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Madrigal Pharmaceuticals | 12.86 Bn | 9.26 Bn | - | 12.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.98% |
| Jun 30, 2026 | -15.46% |
| Mar 31, 2026 | -29.78% |
| Dec 31, 2025 | -18.56% |
| Sep 30, 2025 | -39.68% |
| Jun 30, 2025 | -22.18% |
| Mar 31, 2025 | -57.79% |
| Dec 31, 2024 | -64.84% |
| Sep 30, 2024 | -187.06% |
| Jun 30, 2024 | -1,110.38% |
| Sep 30, 2016 | -33,728.28% |
| Jun 30, 2016 | -13,889.47% |
| Mar 31, 2012 | -9,908.16% |
| Dec 31, 2011 | -299.12% |
| Sep 30, 2011 | -734.25% |
| Jun 30, 2011 | -886.93% |
| Mar 31, 2011 | -959.41% |
| Dec 31, 2010 | -207.21% |
| Sep 30, 2010 | -302.42% |
| Jun 30, 2010 | -269.17% |
API Access
Madrigal Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();